Cargando…
Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
BACKGROUND: Deflazacort is a synthetic corticosteroid characterized by a favourable pharmacokinetic profile, peculiar pharmacodynamic properties and a good safety profile. However, to the best of our knowledge, no dose-conversion table based on direct comparison of relative potencies between deflaza...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216559/ https://www.ncbi.nlm.nih.gov/pubmed/28057083 http://dx.doi.org/10.1186/s40360-016-0111-8 |
_version_ | 1782491936029933568 |
---|---|
author | Parente, Luca |
author_facet | Parente, Luca |
author_sort | Parente, Luca |
collection | PubMed |
description | BACKGROUND: Deflazacort is a synthetic corticosteroid characterized by a favourable pharmacokinetic profile, peculiar pharmacodynamic properties and a good safety profile. However, to the best of our knowledge, no dose-conversion table based on direct comparison of relative potencies between deflazacort and other main corticosteroids is currently available in scientific literature. MAIN BODY: This paper, while reporting a brief review of deflazacort pharmacological properties, its efficacy and tolerability in different clinical areas, has been designed with the specific aim of providing a new dose-conversion table of corticosteroids, including for the first time also deflazacort. SHORT CONCLUSION: We suggest that this new conversion table could be a useful tool for physicians who need to select the appropriate dose of deflazacort in their clinical practice. |
format | Online Article Text |
id | pubmed-5216559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52165592017-01-09 Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids Parente, Luca BMC Pharmacol Toxicol Debate BACKGROUND: Deflazacort is a synthetic corticosteroid characterized by a favourable pharmacokinetic profile, peculiar pharmacodynamic properties and a good safety profile. However, to the best of our knowledge, no dose-conversion table based on direct comparison of relative potencies between deflazacort and other main corticosteroids is currently available in scientific literature. MAIN BODY: This paper, while reporting a brief review of deflazacort pharmacological properties, its efficacy and tolerability in different clinical areas, has been designed with the specific aim of providing a new dose-conversion table of corticosteroids, including for the first time also deflazacort. SHORT CONCLUSION: We suggest that this new conversion table could be a useful tool for physicians who need to select the appropriate dose of deflazacort in their clinical practice. BioMed Central 2017-01-05 /pmc/articles/PMC5216559/ /pubmed/28057083 http://dx.doi.org/10.1186/s40360-016-0111-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Debate Parente, Luca Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids |
title | Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids |
title_full | Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids |
title_fullStr | Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids |
title_full_unstemmed | Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids |
title_short | Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids |
title_sort | deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids |
topic | Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216559/ https://www.ncbi.nlm.nih.gov/pubmed/28057083 http://dx.doi.org/10.1186/s40360-016-0111-8 |
work_keys_str_mv | AT parenteluca deflazacorttherapeuticindexrelativepotencyandequivalentdosesversusothercorticosteroids |